AU2003301851A1 - Azacyclic compounds as orexin receptor antagonist - Google Patents
Azacyclic compounds as orexin receptor antagonistInfo
- Publication number
- AU2003301851A1 AU2003301851A1 AU2003301851A AU2003301851A AU2003301851A1 AU 2003301851 A1 AU2003301851 A1 AU 2003301851A1 AU 2003301851 A AU2003301851 A AU 2003301851A AU 2003301851 A AU2003301851 A AU 2003301851A AU 2003301851 A1 AU2003301851 A1 AU 2003301851A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonist
- orexin receptor
- azacyclic compounds
- azacyclic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0225884.6 | 2002-11-06 | ||
GBGB0225884.6A GB0225884D0 (en) | 2002-11-06 | 2002-11-06 | Novel compounds |
PCT/EP2003/012403 WO2004041816A1 (en) | 2002-11-06 | 2003-11-04 | Azacyclic compounds as orexin receptor antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003301851A1 true AU2003301851A1 (en) | 2004-06-07 |
Family
ID=9947317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003301851A Abandoned AU2003301851A1 (en) | 2002-11-06 | 2003-11-04 | Azacyclic compounds as orexin receptor antagonist |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003301851A1 (en) |
GB (1) | GB0225884D0 (en) |
WO (1) | WO2004041816A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400405A3 (en) * | 2004-02-10 | 2009-03-30 | Sanofi Synthelabo | Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
KR100848747B1 (en) | 2004-03-01 | 2008-07-25 | 액테리온 파마슈티칼 리미티드 | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
US8618102B2 (en) | 2006-07-14 | 2013-12-31 | Merck Sharp & Dohme Corp. | Bridged diazepan orexin receptor antagonists |
WO2008038251A2 (en) * | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.1.0]hexane derivatives |
WO2008065626A2 (en) | 2006-12-01 | 2008-06-05 | Actelion Pharmaceuticals Ltd | 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
PE20081229A1 (en) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | DIAZEPAM OREXIN RECEPTOR ANTAGONISTS REPLACED |
CL2007003827A1 (en) * | 2006-12-28 | 2008-09-26 | Actelion Pharmaceuticals Ltd | COMPOUNDS DERIVED FROM N- (2-AZA-BICYCLE (3.1.0) HEX-3-ILMETIL) AMIDA; AND ITS USE TO PREVENT OR TREAT DEPRESSION, NEUROSIS, SCHIZOPHRENIA, ANXIETY, ADDICTIONS, EPILEPSY, PAIN, HEART DISEASES, AMONG OTHERS. |
CL2008000836A1 (en) | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Thiazolidine derivative compounds, orexin receptor antagonists; pharmaceutical composition that includes them; and its use in the treatment of emotional neurosis, severe depression, psychotic disorders, Alzheimer's, parkinson's, pain, among others. |
BRPI0811842A2 (en) | 2007-05-23 | 2014-11-18 | Merck & Co Inc | COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHODS TO INCREASE SLEEP QUALITY IN A MAMMALIAN PATIENT, TO TREAT INSOMNIA IN A MAMMALIAN PATIENT, AND TO TREAT OR CONTROL OBESITY IN A MAMMALIAN PATIENT |
US8030495B2 (en) | 2007-05-23 | 2011-10-04 | Coleman Paul J | Cyclopropyl pyrrolidine orexin receptor antagonists |
BRPI0814593A2 (en) | 2007-07-27 | 2015-01-20 | Actelion Pharmaceuticals Ltd | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. |
CA2699328A1 (en) | 2007-09-24 | 2009-04-02 | Actelion Pharmaceuticals Ltd | Pyrrolidines and piperidines as orexin receptor antagonists |
RU2010138640A (en) | 2008-02-21 | 2012-03-27 | Актелион Фармасьютиклз Лтд (Ch) | 2-AZA-Bicyclo [2.2.1] HEPTANE DERIVATIVES |
CN102300858A (en) * | 2008-12-02 | 2011-12-28 | 葛兰素集团有限公司 | N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] Hept-4-yl] Methyl}-2-heteroarylamine Derivatives And Uses Thereof |
KR20110091582A (en) * | 2008-12-02 | 2011-08-11 | 글락소 그룹 리미티드 | N-{[(1r,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof |
US20120258957A1 (en) | 2009-11-23 | 2012-10-11 | Matilda Jane Bingham | Heterocyclic derivatives |
JP5588018B2 (en) * | 2009-12-29 | 2014-09-10 | スベン ライフ サイエンシズ リミティド | α4β2 neuronal nicotinic acetylcholine receptor ligand |
AR088352A1 (en) | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE |
US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
NZ628491A (en) | 2012-02-07 | 2016-06-24 | Eolas Therapeutics Inc | Substituted prolines / piperidines as orexin receptor antagonists |
ITMI20120424A1 (en) * | 2012-03-19 | 2013-09-20 | Rottapharm Spa | CHEMICAL COMPOUNDS |
TWI510481B (en) | 2012-06-04 | 2015-12-01 | Actelion Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
AU2013328301A1 (en) | 2012-10-10 | 2015-05-28 | Actelion Pharmaceuticals Ltd | Orexin receptor antagonists which are [ortho bi (hetero-)aryl]-[2-(meta bi (hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives |
JP2016510810A (en) | 2013-03-12 | 2016-04-11 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | Azetidine amide derivatives as orexin receptor antagonists |
UA119151C2 (en) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | Crystalline salt form of (s)-(2-(6-chloro-7-methyl-1 h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist |
PT3077389T (en) | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists |
HUE040555T2 (en) | 2013-12-04 | 2019-03-28 | Idorsia Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives |
EP3180332B1 (en) | 2014-08-13 | 2021-10-27 | Eolas Therapeutics Inc. | Difluoropyrrolidines as orexin receptor modulators |
AU2017217931B2 (en) | 2016-02-12 | 2020-10-22 | Astrazeneca Ab | Halo-substituted piperidines as orexin receptor modulators |
EP3454857A1 (en) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
WO2020007964A1 (en) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives |
WO2020099511A1 (en) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
TW202400149A (en) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2361390A1 (en) * | 1973-12-10 | 1975-06-19 | Merck Patent Gmbh | ISOCHINOLINE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
JP2786479B2 (en) * | 1989-05-31 | 1998-08-13 | 三田工業株式会社 | Image reading processor |
HU227811B1 (en) * | 2000-03-14 | 2012-03-28 | Actelion Pharmaceuticals Ltd | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes |
EP1288202A4 (en) * | 2000-05-11 | 2003-07-02 | Banyu Pharma Co Ltd | N-acyltetrahydroisoquinoline derivatives |
ES2238458T3 (en) * | 2000-06-16 | 2005-09-01 | Smithkline Beecham Plc | PIPERIDINS FOR USE AS ANTAGONISTS OF OREXIN RECEPTORS. |
-
2002
- 2002-11-06 GB GBGB0225884.6A patent/GB0225884D0/en not_active Ceased
-
2003
- 2003-11-04 AU AU2003301851A patent/AU2003301851A1/en not_active Abandoned
- 2003-11-04 WO PCT/EP2003/012403 patent/WO2004041816A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004041816A1 (en) | 2004-05-21 |
GB0225884D0 (en) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301851A1 (en) | Azacyclic compounds as orexin receptor antagonist | |
AP1828A (en) | Muscarinic Acetycholine receptor antagonists | |
AU2003261392A1 (en) | M3muscarinic acetylcholine receptor antagonists | |
AU2003241836A1 (en) | Lpa receptor antagonists | |
AU2003231513A1 (en) | Pgd2 receptor antagonist | |
IL174538A0 (en) | Thrombin receptor antagonists | |
HK1129893A1 (en) | Tricyclic thrombin receptor antagonist | |
IL172822A0 (en) | Muscarnic acetylcholine receptor antagonists | |
PL374674A1 (en) | Mchir antagonists | |
AU2003300952A1 (en) | Indane compounds as ccr5 antagonists | |
AU2002249275A1 (en) | Oxo azabicyclic compounds | |
AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
EP1708703A4 (en) | Chemokine receptor binding compounds | |
EP1648461A4 (en) | Muscarinic acetylcholine receptor antagonists | |
AU2003215549A1 (en) | Mercaptoimidazoles as ccr2 receptor antagonists | |
AU2003267088A1 (en) | Chemokine receptor antagonists as therapeutic agents | |
AU2002347552A1 (en) | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | |
AU2002356369A1 (en) | Xanthine derivatives as muscarinic receptor antagonists | |
AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
IL173337A0 (en) | Receptor | |
AU2003287219A1 (en) | Il-8 receptor antagonists | |
SG131946A1 (en) | Ccr3 receptor antagonists | |
AU2003267802A1 (en) | Quaternary ammonium compounds as muscarinic receptor antagonists | |
IL162534A0 (en) | Novel alkansulfonamides as endotheline antagonists | |
AU2003242244A1 (en) | Chemokine receptor antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |